| Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation T Tanigawa, M Kaneko, K Hashizume, M Kajikawa, H Ueda, M Tajiri, ... Drug metabolism and pharmacokinetics 28 (1), 59-70, 2013 | 106 | 2013 |
| First-in-human phase I study of aprutumab ixadotin, a fibroblast growth factor receptor 2 antibody–drug conjugate (BAY 1187982) in patients with advanced cancer SB Kim, F Meric-Bernstam, A Kalyan, A Babich, R Liu, T Tanigawa, ... Targeted oncology 14, 591-601, 2019 | 63 | 2019 |
| Confirmation of model-based dose selection for a Japanese phase III study of rivaroxaban in non-valvular atrial fibrillation patients M Kaneko, T Tanigawa, K Hashizume, M Kajikawa, M Tajiri, W Mueck Drug metabolism and pharmacokinetics 28 (4), 321-331, 2013 | 57 | 2013 |
| A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: are Japanese phase I studies still needed? K Chiba, H Yoshitsugu, Y Kyosaka, S Iida, K Yoneyama, T Tanigawa, ... The Journal of Clinical Pharmacology 54 (5), 483-494, 2014 | 52 | 2014 |
| Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer I Okamoto, M Miyazaki, R Morinaga, H Kaneda, S Ueda, Y Hasegawa, ... Investigational new drugs 28, 844-853, 2010 | 51 | 2010 |
| Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan–results of a randomised, multicentre phase 3 study H Mikamo, Y Takesue, Y Iwamoto, T Tanigawa, M Kato, Y Tanimura, ... Journal of infection and chemotherapy 24 (6), 434-442, 2018 | 49 | 2018 |
| Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban—an oral, direct Factor Xa inhibitor R Burghaus, K Coboeken, T Gaub, C Niederalt, A Sensse, HU Siegmund, ... Frontiers in physiology 5, 417, 2014 | 22 | 2014 |
| Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma M Niwakawa, K Hashine, R Yamaguchi, H Fujii, Y Hamamoto, K Fukino, ... Investigational new drugs 30, 1046-1054, 2012 | 15 | 2012 |
| Effects of grapefruit juice on the pharmacokinetics of the calcium channel blockers nifedipine and nisoldipine J Azuma, I Yamamoto, T Watase, Y Orii, T Tanigawa, S Terashima, ... Current therapeutic research 59 (9), 619-634, 1998 | 15 | 1998 |
| Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach T Tanigawa, R Heinig, Y Kuroki, S Higuchi Drug metabolism and pharmacokinetics 21 (1), 61-69, 2006 | 9 | 2006 |
| Circadian fluctuation of catecholamines in the cockroach brain-subesophageal ganglion complex detected by HPLC-ECD T Natsukawa, T Tanigawa, M Takeda Biological Rhythm Research 27 (2), 138-147, 1996 | 8 | 1996 |
| A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies V Serelli-Lee, K Ito, A Koibuchi, T Tanigawa, T Ueno, N Matsushima, ... Journal of Personalized Medicine 12 (5), 669, 2022 | 7 | 2022 |
| Effects of grapefruit juice on the pharmacokinetics of the calcium antagonists nifedipine and nisoldipine J Azuma, I Yamamoto, T Watase, Y Seto, T Tanaka, M Katoh, Y Orii, ... JAPANESE PHARMACOLOGY AND THERAPEUTICS 24, 267-276, 1996 | 6 | 1996 |
| アダラート CR 錠の薬物動態に及ぼすグレープフルーツジュースの影響 田中利明， 河野浩一， 奥村一仁， 折井義光， 谷河賞彦， 坪井貴司， ... 臨床薬理 32 (1), 23-33, 2001 | 2 | 2001 |
| Population pharmacokinetics of ramatroban in healthy volunteers and patients with bronchial asthma/perennial allergic rhinitis T TANIGAWA, K OKUMURA, K KAWANO, T MATSUKI, E YUKAWA, ... Drug Metabolism and Pharmacokinetics 12 (2), 121-129, 1997 | 2 | 1997 |
| ラマトロバンの健常者および気管支ぜん息, 通年性鼻アレルギー患者におけるポピュレーションファーマコキネティックス 谷河賞彦， 奥村一仁， 河野浩一， 松木孝道， 湯川榮二， 樋口駿 薬物動態 12 (2), 121-129, 1997 | 2 | 1997 |
| Phase I study of fibroblast growth factor receptor 2 antibody-drug conjugate (FGFR2-ADC) BAY 1187982 in patients with advanced cancer SB Kim, F Meric-Bernstam, J Berlin, S Wittemer-Rump, M Osada, ... CANCER RESEARCH 77, 2017 | 1 | 2017 |
| 2. 新医薬品の臨床開発における M&S の利用 谷河賞彦 臨床薬理 41 (5), 199-203, 2010 | 1 | 2010 |
| Effect of grapefruit juice on the pharmacokinetics of Adalat CR T TANAKA, K KAWANO, K OKUMURA, Y ORII, T TANIGAWA, T TSUBOI, ... Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 32 …, 2001 | 1 | 2001 |
| Characteristics and results of darolutamide, a novel androgen receptor inhibitor; Part 1, efficacy and safety of darolutamide in patients with nonmetastatic castration … M AKIYAMA, C SAKANAKA, T TANIGAWA, T HORIO 泌尿器外科 33 (4), 405-415, 2020 | | 2020 |
